BIO 2017: Industry at a crossroads over section 101

22-06-2017

BIO 2017: Industry at a crossroads over section 101

sonercdem / iStockphoto.com

The biotechnology industry is at a crossroads over 35 USC section 101, which covers patent subject matter eligibility.


BIO 2017, biotechnology, patent, USPTO, section 101, AIPLA, patent subject matter, US Supreme Court

LSIPR